Exercise and Peptide Synergy

Introduction

Lifters often pair peptides with training. Broader stacking is covered in the synergistic compounds overview.

Synergy Mechanisms

GH Peptides and Exercise

Mechanism	Exercise Effect	Peptide Effect	Combined
GH release	Natural increase	Raised	Not measured
Fat oxidation	Increases	Not shown in humans	Unknown
Muscle preservation	Stimulated	Lean mass, not strength	Unknown
Recovery	Natural process	User reports	Unknown

Growth hormone (GH) output rises with exercise intensity (1999 study, 10 men). Over 2 years in older adults, MK-677 added lean mass but didn't cut fat or raise strength, and FDA's 2024 reviews found no human effectiveness data for CJC-1295 or ipamorelin.

Exercise Type Synergies

Resistance Training

Peptide	Evidence	Claimed Mechanism	Reported Timing
GH secretagogues	Ipamorelin moderate	Anabolic boost (user claim)	Pre-training
IGF-1 LR3	Preliminary	Muscle effects (rodent data)	Post-training
BPC-157	Emerging	Recovery (user claim)	Post-training

Cardiovascular Training

Peptide	Evidence	Claimed Mechanism	Reported Timing
Fragment 176-191 / AOD-9604	Failed human trials	Fat oxidation (rodent data)	Fasted cardio
Ipamorelin	Moderate	Metabolic boost (user claim)	Pre-cardio
MOTS-c	No human data; analog CB4211 shelved	Mitochondrial (mouse data)	Untested

In the OPTIONS trial, oral AOD-9604 (0.25-1 mg daily) plus supervised diet and exercise didn't beat placebo for weight loss in 502 adults with obesity. Users inject it, an untested route (AOD-9604 profile).

HIIT

Claims that GH secretagogues amplify the exercise GH spike, or that fat-loss peptides extend afterburn, haven't been measured.

Reported Protocols

These untested schedules come from forum and vendor guides, which place pre-workout doses 30-60 minutes out.

Fat Loss Focus

Training Day	Reported Protocol
AM fasted cardio	Fragment 176-191 pre-cardio
PM weights	GH secretagogue pre-workout
Evening	Recovery peptides

Body Recomposition

Training Day	Reported Protocol
Pre-workout	Ipamorelin 30 min before
Post-workout	IGF-1 LR3 after (users report hypoglycemia)
Before bed	CJC-1295 (DAC form lasts 6+ days)

What We Still Don't Know

Of the peptides named here, only AOD-9604 has a human trial alongside exercise, and it failed. As of October 2026, WADA bans every peptide named here at all times.